curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

[Trial of device that is not approved or cleared by the U.S. FDA]

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Sponsors: [Redacted] Withheld Sponsors: [Redacted] Withheld 

A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Conditions: Obesity; Overweight and/or Obesity; Overweight; Treatment Of Obesity Interventions: Drug: Semaglutide; Drug: Tirzepatide; Drug: Berobenatide Sponsors: Pfizer Not yet recruiting Conditions: Obesity; Overweight and/or Obesity; Overweight; Treatment Of...

NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy Obesity; Obesity Interventions: Drug: GLP-1 Receptor Agonist Therapy Sponsors: Istanbul Saglik Bilimleri University Not yet recruiting Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy Obesity;...

Predicting Early Circulatory Deterioration After Short-Acting Beta-Blocker Treatment in Intensive Care Patients

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Conditions: Critical Illness Interventions: Drug: Esmolol; Drug: Landiolol Sponsors: Shanghai Zhongshan Hospital Completed Conditions: Critical Illness Interventions: Drug: Esmolol; Drug: Landiolol Sponsors: Shanghai Zhongshan Hospital...

Control of Myopia in Young Children Using H.O.P.E. Lenses Combined With 0.02% Atropine Eye Drops

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Conditions: Myopia Interventions: Device: High-order Phase Element Array Microstructure Design Lens (H.O.P.E.); Drug: 0.02% Atropine Sulfate Eye Drops Sponsors: Ruihua Wei; Tianjin Medical University Eye Hospital Not yet recruiting Conditions: Myopia Interventions:...

Bayesian Optimization of DBS for Gait

by palligoelme@gmail.com | Sep 28, 2026 | Clinical Trials

​ Conditions: Parkinson Disease (PD) Interventions: Other: Deep Brain Stimulation Sponsors: University of Minnesota Recruiting Conditions: Parkinson Disease (PD) Interventions: Other: Deep Brain Stimulation Sponsors: University of Minnesota...
« Older Entries
Next Entries »

Recent Posts

  • GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
  • Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma
  • ABVN Phase 2 – Vagal Maneuvers
  • A Test of Acceptance-based Bibliotherapy for Hoarding Disorder
  • Semaglutide for the Treatment of Cannabis Use Disorder

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®